Impax Asset Management Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $26.2M | Buy |
204,194
+53,257
| +35% | +$6.23M | 0.17% | 92 |
|
|
2026
Q1 | $18.2M | Buy |
150,937
+42,387
| +39% | +$4.89M | 0.13% | 105 |
|
|
2025
Q4 | $11.4M | Sell |
108,550
-35,415
| -25% | -$3.32M | 0.07% | 141 |
|
|
2025
Q3 | $12.1M | Sell |
143,965
-3,106
| -2% | -$256K | 0.07% | 132 |
|
|
2025
Q2 | $11.6M | Sell |
147,071
-252,213
| -63% | -$20M | 0.07% | 129 |
|
|
2025
Q1 | $35.8M | Sell |
399,284
-46,275
| -10% | -$4.32M | 0.22% | 90 |
|
|
2024
Q4 | $44.3M | Sell |
445,559
-126,222
| -22% | -$13M | 0.2% | 87 |
|
|
2024
Q3 | $64.9M | Buy |
571,781
+48,368
| +9% | +$5.75M | 0.26% | 78 |
|
|
2024
Q2 | $64.8M | Sell |
523,413
-112,033
| -18% | -$14.4M | 0.26% | 78 |
|
|
2024
Q1 | $83.8M | Sell |
635,446
-188,400
| -23% | -$23.2M | 0.32% | 77 |
|
|
2023
Q4 | $89.8M | Buy |
823,846
+42,810
| +5% | +$4.44M | 0.36% | 73 |
|
|
2023
Q3 | $80.4M | Buy |
781,036
+5,523
| +0.7% | +$595K | 0.36% | 73 |
|
|
2023
Q2 | $89.5M | Buy |
775,513
+6,545
| +0.9% | +$743K | 0.36% | 74 |
|
|
2023
Q1 | $81.8M | Buy |
768,968
+110,085
| +17% | +$11.9M | 0.34% | 75 |
|
|
2022
Q4 | $73.1M | Buy |
658,883
+115,995
| +21% | +$11.9M | 0.33% | 81 |
|
|
2022
Q3 | $46.8M | Sell |
542,888
-1,197
| -0.2% | -$107K | 0.24% | 88 |
|
|
2022
Q2 | $49.6M | Buy |
544,085
+63,102
| +13% | +$5.59M | 0.24% | 85 |
|
|
2022
Q1 | $39.5M | Sell |
480,983
-68
| -0% | -$5.36K | 0.16% | 100 |
|
|
2021
Q4 | $36.9M | Buy |
481,051
+4,944
| +1% | +$394K | 0.13% | 99 |
|
|
2021
Q3 | $35.8M | Buy |
476,107
+4,294
| +0.9% | +$327K | 0.15% | 99 |
|
|
2021
Q2 | $36.7M | Buy |
471,813
+54,985
| +13% | +$4.09M | 0.16% | 94 |
|
|
2021
Q1 | $30.7M | Buy |
416,828
+29,589
| +8% | +$2.18M | 0.16% | 89 |
|
|
2020
Q4 | $30.2M | Buy |
387,239
+80,209
| +26% | +$6.13M | 0.19% | 75 |
|
|
2020
Q3 | $24.3M | Hold |
307,030
| – | – | 0.21% | 80 |
|
|
2020
Q2 | $22.7M | Hold |
307,030
| – | – | 0.23% | 77 |
|
|
2020
Q1 | $22.5M | Hold |
307,030
| – | – | 0.3% | 72 |
|
|
2019
Q4 | $26.6M | Buy |
307,030
+18,582
| +6% | +$1.53M | 0.3% | 66 |
|
|
2019
Q3 | $23.2M | Buy |
288,448
+22,322
| +8% | +$1.79M | 0.3% | 68 |
|
|
2019
Q2 | $21.3M | Hold |
266,126
| – | – | 0.28% | 69 |
|
|
2019
Q1 | $21.1M | Buy |
266,126
+37,662
| +16% | +$2.82M | 0.29% | 68 |
|
|
2018
Q4 | $16.7M | Buy |
+228,464
| New | +$16.1M | 0.27% | 70 |
|
Other funds holding MRK
Impax Asset Management Group's MRK Position: Q2 2026 in Review
Impax Asset Management Group increased its Merck (MRK) stake by 35% in Q2 2026, buying an estimated $6.23M and bringing the position to 204,194 shares worth $26.2M. The position accounts for 0.17% of the portfolio, ranked #92.
Impax Asset Management Group first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. The position peaked at $89.8M in Q4 2023. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Impax Asset Management Group held 204,194 shares of Merck worth $26.2M as of Q2 2026.
- Impax Asset Management Group bought 53,257 Merck shares in Q2 2026, an estimated $6.23M.
- Merck made up 0.17% of Impax Asset Management Group's portfolio in Q2 2026, its #92 holding.
- Impax Asset Management Group first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- Impax Asset Management Group's Merck position peaked at $89.8M in Q4 2023.
- 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Impax Asset Management Group's 13F filing for Q2 2026, filed 11 Aug 2026.